Exploring the relationship of SSTR2 immunohistochemical and textural features to neuroendocrine tumor grade

被引：0
|
作者：
Sherbansky, Leah
Savickas, Patrick
Phanse, Sharwari
Casey, Jack
Feldstein, Julie
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4315
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4315
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Immunohistochemical Profiling of SSTR2 and HIF-2α with the Tumor Microenvironment in Pheochromocytoma and Paraganglioma
    Uchihara, Masaki
    Tanabe, Akiyo
    Kojima, Yuki
    Shimoi, Tatsunori
    Maeshima, Akiko Miyagi
    Umamoto, Kotaro
    Shimomura, Akihiko
    Shimizu, Chikako
    Yamazaki, Yuto
    Nakamura, Eijiro
    Matsui, Yoshiyuki
    Takemura, Nobuyuki
    Miyazaki, Hideyo
    Sudo, Kazuki
    Yonemori, Kan
    Kajio, Hiroshi
    CANCERS, 2024, 16 (12)
  • [2] A Retrospective Analysis of SSTR2 and MGMT Expression in Neuroendocrine Neoplasms
    Liu, Z.
    Chi, Y.
    Shi, S.
    Geng, H.
    NEUROENDOCRINOLOGY, 2019, 108 : 126 - 126
  • [3] PATTERNS OF EXPRESSION OF SSTR1 AND SSTR2 SOMATOSTATIN RECEPTOR SUBTYPES IN THE HYPOTHALAMUS OF THE ADULT-RAT - RELATIONSHIP TO NEUROENDOCRINE FUNCTION
    BEAUDET, A
    GREENSPUN, D
    RAELSON, J
    TANNENBAUM, GS
    NEUROSCIENCE, 1995, 65 (02) : 551 - 561
  • [4] DETECTION OF SOMATOSTATIN RECEPTOR SUBTYPE-2 (SSTR2) IN ESTABLISHED TUMORS AND TUMOR-CELL LINES - EVIDENCE FOR SSTR2 HETEROGENEITY
    TAYLOR, JE
    THEVENIAU, MA
    BASHIRZADEH, R
    REISINE, T
    EDEN, PA
    PEPTIDES, 1994, 15 (07) : 1229 - 1236
  • [5] Somatostatin Receptor 2 (SSTR2) Expression, as well as Combined Somatostatin and SSTR2 Expression, is Associated with Better Clinical Outcome and Prognosis in Rectal Neuroendocrine Tumors
    Kim, Joo Young
    Hong, Seung-Mo
    Kim, Jisup
    LABORATORY INVESTIGATION, 2024, 104 (03) : S738 - S738
  • [6] Detection of SSTR2 and 5 Expression on Circulating Tumour Cells in Neuroendocrine Tumours
    Childs, A.
    Vesely, C.
    Ensell, L.
    Luong, T.
    Caplin, M.
    Toumpanakis, C.
    Thirlwell, C.
    Hartley, J.
    Meyer, T.
    NEUROENDOCRINOLOGY, 2016, 103 : 10 - 11
  • [7] Immunohistochemical Detection of Therapeutic Biomarkers, SSTR2, SSTR5 and p-mTOR, in Various Human Pituitary Adenomas
    Osamura, Robert
    Matsuda, Midori
    Inomoto, Chie
    Kajiwara, Hiroshi
    Matsuno, Akira
    Teramoto, Akira
    LABORATORY INVESTIGATION, 2015, 95 : 140A - 140A
  • [8] Proof-of-concept of a pretargeting strategy mediated by sstr2 antagonist for the therapy of neuroendocrine tumours
    Koustoulidou, S.
    Handula, M.
    Nonnekens, J.
    Hendriks-de Jong, M.
    Seimbille, Y.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S193 - S193
  • [9] Immunohistochemical Detection of Therapeutic Biomarkers, SSTR2; SSTR5 and p-mTOR, in Various Human Pituitary Adenomas
    Osamura, Robert
    Matsuda, Midori
    Inomoto, Chie
    Kajiwara, Hiroshi
    Matsuno, Akira
    Teramoto, Akira
    MODERN PATHOLOGY, 2015, 28 : 140A - 140A
  • [10] Development of 203Pb-labeled SSTR2 radioligands for neuroendocrine tumors (NETs) imaging
    Chapeau, Dylan
    Koustoulidou, Sofia
    de Blois, Erik
    Konijnenberg, Mark
    De Jong, Marion
    Seimbille, Yann
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 108 : S54 - S55
12345